- 全部删除
您的购物车当前为空
Garivulimab (BGB-A333)为人源化IgG1变体单克隆抗体,专一性结合PD-L1,阻断PD-L1与PD-1相互作用,展现抗肿瘤活性。
Garivulimab (BGB-A333)为人源化IgG1变体单克隆抗体,专一性结合PD-L1,阻断PD-L1与PD-1相互作用,展现抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 |
Garivulimab 相关产品
| 产品描述 | Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody targeting and binding specifically to PD-L1, thereby selectively inhibiting the PD-L1/PD-1 interaction. This action grants Garivulimab its antitumor activity [1]. |
| CAS No. | 2342597-81-1 |
| 存储 | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容